COVID-19 Lockdown Linked to Decline in Acute Myocardial Infarction Hospitalizations

September 23, 2020

This decrease in hospital admissions had no association with regional prevalence of COVID-19.

Rivaroxaban an Option to Treat Venous Thromboembolism in Pediatric Patients

September 21, 2020

Treatments for VTE in children fall short as they require frequent monitoring and include unpredictable food and drug interactions.

Study Finds Concerning Lack of Influenza Vaccination Among ASCVD Patients

September 19, 2020

Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.

Ustekinumab Associated with Increased Risk of Serious Cardiovascular Events

September 18, 2020

Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.

New Targeted Inhibitor Offers Promise for Patients with Symptomatic Obstructive HCM

September 17, 2020

Current therapies focus on relief of symptoms, but there is still an unmet need to address and target the molecular defects of hypertrophic cardiomyopathy.

Post-Discharge VTE Following COVID-19 Hospitalization Is Low

September 17, 2020

Post-discharge thromboprophylaxis is not necessary.

Edoxaban Safe And Effective Treating Deep Vein Thrombosis

September 17, 2020

The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.

No Cardiovascular Benefit from Phosphate Binders in Chronic Kidney Disease Patients

September 16, 2020

Lanthanum is commonly prescribed to CKD patients to help reduce the risk of bone and cardiovascular disease.

Jeffrey Curtis, MD, MS, MPH: The Future of Rheumatological Care

September 15, 2020

Care of rheumatic patients must factor in cradiovascular risk and conditions.

Jeffrey Curtis, MD, MS, MPH: The Responsibility of Cardiovascular Risk Management in Rheumatology

September 14, 2020

An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.